Welcome to our dedicated page for Biolargo news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on Biolargo stock.
Biolargo, Inc. (BLGO) delivers innovative cleantech solutions for critical environmental challenges, from advanced water treatment to sustainable energy storage. This news hub provides investors and industry professionals with timely updates on the company’s progress in commercializing its technologies.
Discover official press releases, financial announcements, and operational milestones related to BLGO’s core initiatives: PFAS remediation systems, water treatment innovations, Cellinity energy storage technology, and strategic partnerships. The page serves as a neutral, factual resource for tracking the company’s execution of its environmental technology roadmap.
Key updates include regulatory developments, patent approvals, partnership agreements, and product commercialization efforts. All content is curated to meet investor needs for decision-ready information while adhering to financial disclosure standards.
Bookmark this page or check back regularly for verified updates directly from Biolargo and trusted financial news sources. For historical context, explore archived announcements demonstrating the company’s evolving cleantech portfolio.
BioLargo, Inc. (OTCQB:BLGO) has filed its Quarterly Report for Q3 2021, revealing a 7% increase in consolidated revenue to $712,000, largely driven by a 73% rise in the engineering division. The company's net loss decreased to $1.3 million, down from $2.1 million the previous year due to reduced interest expenses. Key progress includes successful PFAS treatment tests with prospective clients, completion of a prototype for Garratt-Callahan, and promising pilot results for the AOS technology, solidifying its position for future growth.
BioLargo, Inc. (OTCQB:BLGO) will host an investor webcast on November 17, 2021, at 8:00 AM PST / 11:00 AM EST, to discuss its financial results and recent commercial milestones. The event is public and will include a Q&A session. Investors can access the live stream and replay through the company's website. BioLargo specializes in sustainable environmental technologies, holding numerous patents and executing various projects, while also emphasizing partnerships and innovative solutions to environmental challenges.
BioLargo, Inc. (OTCQB:BLGO) announced a peer-reviewed article confirming the efficacy of its water treatment technology, the Advanced Oxidation System (AOS). Published in ACS ES&T Water, the study reveals that AOS generates highly energetic iodine molecules, enhancing disinfection efficiency. Currently being tested at a municipal wastewater facility, AOS demonstrates superior performance and lower energy consumption compared to traditional methods. The research employed advanced measurement techniques, establishing AOS as a significant advancement in sustainable water treatment technology.
BioLargo, Inc. (BLGO) shared a letter to stockholders on September 30, 2021, outlining strategic partnerships to enhance its market presence. Notably, BioLargo is launching a wastewater treatment product with Garratt-Callahan, aiming to sell 25-35 units within the first year. They also plan to commercially launch their PFAS treatment device, AEC, in early 2022. Additionally, a new consumer product partnership is underway with Ikigai Holdings. Overall, BioLargo is focusing on revenue growth and improving financial health, having significantly reduced debt while pursuing sustainable business solutions.
BioLargo, Inc. (OTCQB:BLGO) will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021. CEO Dennis Calvert will discuss the company's innovative cleantech products, including its new PFAS Testing Program. The presentation is scheduled for September 13 at 7:00 am ET and will be available on demand for 90 days. Investors can register for free to view the presentation. BioLargo focuses on environmental technologies to tackle PFAS contamination and enhance water treatment solutions.
BioLargo, Inc. (OTCQB:BLGO) has launched a new PFAS Testing Program to help customers identify PFAS contamination in their water. This program addresses the growing regulatory challenges regarding PFAS, a group of harmful chemicals found in drinking water. The testing provides accurate results, enabling the company to recommend appropriate treatment solutions. BioLargo's Aqueous Electrostatic Concentrator (AEC) offers a sustainable method for PFAS removal, generating significantly less waste than conventional methods. This initiative aims to support municipalities facing PFAS-related water well closures.
BioLargo, Inc. (OTCQB:BLGO) will participate in Water Solutions 6 on August 26, 2021, from 1:30 pm to 5:00 pm PT. This virtual conference focuses on water conservation and innovations. Tonya Chandler, BioLargo's Director of Strategic Marketing, will present its technology for removing PFAS contaminants from water. As a title sponsor, BioLargo encourages public registration with the promo code WS6BLGOCOMP. The event features notable speakers, including state water officials and industry leaders.
BioLargo (OTCQB:BLGO) announced key developments in its Quarterly Report on August 17, 2021, highlighting an 11% increase in consolidated revenue to $464,000 for Q2 2021. The company has made strides in commercializing PFAS treatment technology and reducing its debt by over $4 million since 2019. New contracts worth $1.2 million are expected to boost cash flow. A peer-reviewed paper validates the safety of its water treatment technology, supporting its market position. The company is actively pursuing further significant revenue opportunities.
BioLargo, Inc. (OTCQB:BLGO) will host a webcast on August 17, 2021, at 8:00 am PST / 11:00 am EST, to discuss its financial results and recent events. The public is invited to participate. Replay of the webcast and teleconference will be available for a limited time on their Investor Relations webpage. BioLargo focuses on innovative technologies addressing environmental issues, such as PFAS contamination and water treatment, supported by over 80 awarded grants and numerous pilot projects. For more details, visit BioLargo's website.
